Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Sales (2016 - 2025)

Historic Return on Sales for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Niagen Bioscience's Return on Sales rose 600.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.09% for FY2024, which is 1400.0% up from last year.
  • Per Niagen Bioscience's latest filing, its Return on Sales stood at 0.13% for Q3 2025, which was up 600.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Sales ranged from a high of 0.25% in Q4 2024 and a low of 0.51% during Q3 2021
  • Over the past 5 years, Niagen Bioscience's median Return on Sales value was 0.07% (recorded in 2022), while the average stood at 0.12%.
  • Per our database at Business Quant, Niagen Bioscience's Return on Sales tumbled by -2100bps in 2021 and then skyrocketed by 3600bps in 2023.
  • Quarter analysis of 5 years shows Niagen Bioscience's Return on Sales stood at 0.3% in 2021, then skyrocketed by 77bps to 0.07% in 2022, then surged by 108bps to 0.01% in 2023, then surged by 4483bps to 0.25% in 2024, then tumbled by -45bps to 0.13% in 2025.
  • Its Return on Sales was 0.13% in Q3 2025, compared to 0.12% in Q2 2025 and 0.17% in Q1 2025.